当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Machine Translation in Neonatal Medicine Review

Muthuram Perera

While AI clinical decision support tools appear superior to rule-based tools in many situations, their use can pose additional challenges. An example of this is the lack of large data sets and the existence of imbalanced data (e.g. due to low rates of adverse events) commonly observed in neonatal medicine. This paper describes the latest and most powerful applications of AI in neonatal medicine and highlights future research directions relevant to the neonatal population. AI applications currently being tested in neonatology include vital signs monitoring, disease prediction (respiratory distress syndrome, bronchopulmonary dysplasia, apnea of prematurity), risk stratification retinopathy of prematurity, intestinal perforation, jaundice it is included. including tools for neurological diagnosis and prognostic support. New image recognition techniques (especially useful for staging, neuroimaging, etc.) and timely detection of infections. Tools like these that support neonatal doctors in their daily practice could be very revolutionary in the near future. On the other hand, in order to use AI technology correctly, it is important to be aware of its limitations.